HKD 3.39
(-0.88%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 336.55 Million HKD | 89.65% |
2022 | 67.24 Million HKD | 795.88% |
2021 | -9.66 Million HKD | 84.39% |
2020 | -61.89 Million HKD | -180.87% |
2019 | 76.53 Million HKD | -40.66% |
2018 | 128.97 Million HKD | 60.15% |
2017 | 80.53 Million HKD | 49.46% |
2016 | 53.88 Million HKD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 30.94 Million HKD | 0.0% |
2023 Q4 | 53.39 Million HKD | 0.0% |
2023 Q2 | 74.13 Million HKD | 0.0% |
2023 FY | 127.52 Million HKD | 89.65% |
2022 Q4 | 27.4 Million HKD | 0.0% |
2022 FY | 67.24 Million HKD | 795.88% |
2022 Q2 | 39.83 Million HKD | 0.0% |
2021 FY | -9.66 Million HKD | 84.39% |
2021 Q2 | -16.03 Million HKD | 0.0% |
2021 Q4 | 6.36 Million HKD | 0.0% |
2020 Q2 | -32.16 Million HKD | 0.0% |
2020 Q4 | -18.08 Million HKD | 0.0% |
2020 FY | -61.89 Million HKD | -180.87% |
2019 Q4 | 15.97 Million HKD | 0.0% |
2019 Q2 | 63.33 Million HKD | 0.0% |
2019 FY | 76.53 Million HKD | -40.66% |
2018 Q4 | 18.58 Million HKD | 0.0% |
2018 FY | 128.97 Million HKD | 60.15% |
2018 Q2 | 33.84 Million HKD | 0.0% |
2018 Q1 | 33.84 Million HKD | 0.0% |
2017 Q1 | 19.86 Million HKD | 0.0% |
2017 Q2 | 19.86 Million HKD | 0.0% |
2017 Q4 | 33.84 Million HKD | 0.0% |
2017 FY | 80.53 Million HKD | 49.46% |
2016 FY | 53.88 Million HKD | 0.0% |
2016 Q4 | 19.86 Million HKD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
China Healthwise Holdings Limited | -112.57 Million HKD | 398.948% |
Beijing Tong Ren Tang Chinese Medicine Company Limited | 624.14 Million HKD | 46.079% |